JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 50 filers reported holding JASPER THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,556 | -18.4% | 110,792 | +59.7% | 0.04% | -18.5% |
| Q2 2023 | $95,034 | +73.3% | 69,367 | +129.0% | 0.05% | +92.9% |
| Q1 2023 | $54,827 | -0.4% | 30,290 | -73.4% | 0.03% | -3.4% |
| Q4 2022 | $55,051 | -41.4% | 114,000 | -4.8% | 0.03% | -42.0% |
| Q3 2022 | $94,000 | +36.2% | 119,800 | +246.0% | 0.05% | +51.5% |
| Q2 2022 | $69,000 | -41.5% | 34,625 | +6.4% | 0.03% | -25.0% |
| Q1 2022 | $118,000 | – | 32,550 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 11,219,036 | $14,848,445 | 13.79% |
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $11,671,918 | 12.26% |
| Ally Bridge Group (NY) LLC | 2,517,232 | $3,448,608 | 4.18% |
| Altium Capital Management LP | 2,868,000 | $3,929,160 | 2.97% |
| Soleus Capital Management, L.P. | 7,775,980 | $10,653,093 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,274,008 | $5,855,391 | 0.91% |
| Octagon Capital Advisors LP | 4,468,114 | $6,121,316 | 0.85% |
| Carlyle Group Inc. | 8,761,891 | $11,828,553 | 0.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,040,000 | $4,164,800 | 0.39% |
| BVF INC/IL | 9,900,000 | $13,563,000 | 0.38% |